Peter Arkwright

Dr. Peter Arkwright is a Senior Lecturer/Consultant in Paediatric Allergy & Immunology at the University of Manchester and Royal Manchester Children's Hospital. His research focuses on allergic and immune diseases, particularly atopic dermatitis and immunodeficiencies, with over 180 peer-reviewed publications. He has held editorial roles, including Assistant Editor for Journal of Allergy and Clinical Immunology: In Practice, and contributes to clinical care, teaching, and policy through roles like Clinical Chair of the North West Paediatric Allergy Network. His academic qualifications include MB BS (University of Western Australia, 1984) and D Phil (Oxford University, 1989).

• Education:
• MB BS, University of Western Australia (1984)
• BMedSci (Hons), University of Western Australia
• D Phil, Oxford University (1989)

Research Interests: Dr. Arkwright investigates Inborn Errors of Immunity (IEI), genetic/environmental factors in atopic dermatitis, and novel treatments for immune disorders. His work emphasizes translational research to bridge discovery and clinical application, including studies on Staphylococcus aureus in dermatitis pathogenesis and biologic therapies.

Articles Trends: Recent publications focus on dupilumab efficacy in pediatric AD, immunotherapy for peanut allergies, and genetic deficiencies like DIAPH1 and RIPK1. His work spans clinical trials, molecular mechanisms, and treatment outcomes.

• Awards:
• BSACI William Frankland Award (2024)
• Poster Prize Presentations (2011, 2018)

Advising & Grants: He advises on immunodeficiency networks (PID UK) and chairs committees like the North West Paediatric Allergy Network. His grants support research on immune disorders and clinical trials.

Labs/Teams: Collaborates with multidisciplinary teams at the University of Manchester, including the Lydia Becker Institute, focusing on immune system research and clinical translation.